Evidence map›Paper›PMID 37543650›Full record

ArticleJournal of ovarian research2023

Novel corticotropin-releasing hormone receptor genes (CRHR1 and CRHR2) linkage to and association with polycystic ovary syndrome.

Mutaz Amin, Nicholas Horst, Rongling Wu, Claudia Gragnoli

Open access · goldAbstract read
In one paragraph

Article in Journal of ovarian research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 5 countries.

Mutaz AminINSERM, US14-Orphanet, 75014, Paris, France.
Nicholas HorstDivision of Endocrinology, Department of Medicine, Creighton University School of Medicine, Omaha, NE, 68124, USA.
Rongling WuDepartment of Public Health Sciences, Penn State College of Medicine, Hershey, PA, 17033, USA.
Claudia GragnoliDivision of Endocrinology, Department of Medicine, Creighton University School of Medicine, Omaha, NE, 68124, USA. claudia.gragnoli@gmail.com.
Al-Neelain University · SDCreighton University · USPenn State Milton S. Hershey Medical Center · USUniversità Campus Bio-Medico · IT

Funding

Nebraska Department of Health and Human Services Funds received under Nebraska Laws 2021, LB 380, Section 109
6 · The paper itself

Abstract

backgroundWomen with polycystic ovarian syndrome (PCOS) have increased hypothalamic-pituitary-adrenal (HPA) axis activation, pro-inflammatory mediators, and psychological distress in response to stressors. In women with PCOS, the corticotropin-releasing hormone (CRH) induces an exaggerated HPA response, possibly mediated by one of the CRH receptors (CRHR1 or CRHR2). Both CRHR1 and CRHR2 are implicated in insulin secretion, and variants in CRHR1 and CRHR2 genes may predispose to the mental-metabolic risk for PCOS.

methodsWe phenotyped 212 Italian families with type 2 diabetes (T2D) for PCOS following the Rotterdam diagnostic criteria. We analyzed within CRHR1 and CRHR2 genes, respectively, 36 and 18 microarray-variants for parametric linkage to and/or linkage disequilibrium (LD) with PCOS under the recessive with complete penetrance (R1) and dominant with complete penetrance (D1) models. Subsequentially, we ran a secondary analysis under the models dominant with incomplete penetrance (D2) and recessive with incomplete penetrance (R2).

resultsWe detected 22 variants in CRHR1 and 1 variant in CRHR2 significantly (p < 0.05) linked to or in LD with PCOS across different inheritance models.

conclusionsThis is the first study to report CRHR1 and CRHR2 as novel risk genes in PCOS. In silico analysis predicted that the detected CRHR1 and CRHR2 risk variants promote negative chromatin activation of their related genes in the ovaries, potentially affecting the female cycle and ovulation. However, CRHR1- and CRHR2-risk variants might also lead to hypercortisolism and confer mental-metabolic pleiotropic effects. Functional studies are needed to confirm the pathogenicity of genes and related variants.

Indexed as

Diabetes Mellitus, Type 2Polycystic Ovary SyndromeCorticotropin-Releasing HormoneCRF Receptor, Type 1FemaleHumansHypothalamo-Hypophyseal SystemReceptors, Corticotropin-Releasing HormoneCorticotropin-Releasing HormoneCRF Receptor, Type 1CRF receptor type 2Receptors, Corticotropin-Releasing HormoneAssociationCorticotropin-releasing hormone receptorCortisolCRHRGeneHPA-axisHypothalamic–pituitary–adrenal axisInfertilityOvaryPCOSPolycystic ovarian syndrome

Identifiers

PMID37543650
PMCPMC10403835
OpenAlexW4385606957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.